Learning to live with patency of the ductus arteriosus in preterm infants
- PMID: 21448203
- DOI: 10.1038/jp.2010.175
Learning to live with patency of the ductus arteriosus in preterm infants
Abstract
Treatment of persistent patency of the ductus arteriosus in preterm infants remains heterogeneous and controversial. Routine early treatment to induce ductal closure is not beneficial, but the potential criteria for, timing of, methods for and benefits of later ductal closure have not been determined. Management strategies for infants awaiting spontaneous closure or meeting criteria for treatment may be based on pathophysiological considerations but require evaluation in clinical trials. Better diagnostic tools allowing the identification of infants who might benefit from ductal closure, supplemented by data from clinical trials confirming realization of that potential, are urgently needed.
Similar articles
-
Patent ductus arteriosus: to treat or not to treat?Arch Dis Child Fetal Neonatal Ed. 2012 Mar;97(2):F80-2. doi: 10.1136/archdischild-2011-300381. Epub 2011 Dec 15. Arch Dis Child Fetal Neonatal Ed. 2012. PMID: 22174019
-
Patent ductus arteriosus in the preterm infant: new insights into pathogenesis and clinical management.J Matern Fetal Neonatal Med. 2010 Oct;23 Suppl 3:34-7. doi: 10.3109/14767058.2010.509920. J Matern Fetal Neonatal Med. 2010. PMID: 20836735 Review.
-
A comparison of ibuprofen and indomethacin for closure of patent ductus arteriosus.N Engl J Med. 2000 Sep 7;343(10):674-81. doi: 10.1056/NEJM200009073431001. N Engl J Med. 2000. PMID: 10974130 Clinical Trial.
-
Failure of ductus arteriosus closure is associated with increased mortality in preterm infants.Pediatrics. 2009 Jan;123(1):e138-44. doi: 10.1542/peds.2008-2418. Pediatrics. 2009. PMID: 19117835
-
Therapeutic closure of the ductus arteriosus: benefits and limitations.J Matern Fetal Neonatal Med. 2009;22 Suppl 3:14-20. doi: 10.1080/14767050903198132. J Matern Fetal Neonatal Med. 2009. PMID: 19925358 Review.
Cited by
-
Trends and variation in management and outcomes of very low-birth-weight infants with patent ductus arteriosus.Pediatr Res. 2016 Dec;80(6):785-792. doi: 10.1038/pr.2016.166. Epub 2016 Aug 10. Pediatr Res. 2016. PMID: 27509008
-
The timing of surgical ligation for patent ductus arteriosus is associated with neonatal morbidity in extremely preterm infants born at 23-25 weeks of gestation.J Korean Med Sci. 2014 Apr;29(4):581-6. doi: 10.3346/jkms.2014.29.4.581. Epub 2014 Apr 1. J Korean Med Sci. 2014. PMID: 24753708 Free PMC article.
-
Effect of Nonintervention vs Oral Ibuprofen in Patent Ductus Arteriosus in Preterm Infants: A Randomized Clinical Trial.JAMA Pediatr. 2020 Aug 1;174(8):755-763. doi: 10.1001/jamapediatrics.2020.1447. JAMA Pediatr. 2020. PMID: 32539121 Free PMC article.
-
Natural evolution of the patent ductus arteriosus in the extremely premature newborn and respiratory outcomes.J Perinatol. 2022 May;42(5):642-648. doi: 10.1038/s41372-021-01277-2. Epub 2021 Nov 23. J Perinatol. 2022. PMID: 34815521
-
The Ideal Timing of Bedside Surgical Ligation of Patent Ductus Arteriosus in Premature Babies Less Than 30 Gestational Weeks.Turk Arch Pediatr. 2021 Jul;56(4):300-307. doi: 10.5152/TurkArchPediatr.2021.21010. Turk Arch Pediatr. 2021. PMID: 35929851 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical